Osmo

Hugging Face is on a mission to advance and democratize Natural Language Processing.

Eikon Therapeutics is pioneering a new method of drug discovery based on tracking and measuring the movement of individual proteins in living cells.

Osmo is using an odor map and Generative AI to create a new generation of better, safer, environmentally-friendly aroma molecules.

Benchling is transforming research and development with the industry's most widely adopted Life Sciences R&D Cloud.

Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.

Sakana AI is a Tokyo-based R&D company on a quest to build a new kind of foundation model based on nature-inspired intelligence.

ESM3 is the first generative AI model for biology that simultaneously reasons over the sequence, structure, and function of proteins. This enables scientists to understand and create new proteins, making biology programmable.

Physical Intelligence is building a foundation model for robotics, bringing general-purpose AI into the physical world.